MRC1 and mismatch repair cancer syndrome 1: (30) also suggested that POLE sequencing should be performed before immunohistochemistry evaluation for MMR status, since the expression loss for MMR proteins in a POLE-mutated case would be assigned to the dMMR (MMR deficiency) subgroup rather than POLE-positive subgroup.